Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Investment analysts at Bank of America started coverage on shares of Revolution Medicines (NASDAQ:RVMD – Get Rating) in a report released on Friday, The Fly reports. The firm set a “neutral” rating on the stock. RVMD has been the topic of several other research reports. Stifel Nicolaus raised Revolution Medicines from a “hold” rating to […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) Director Thilo Schroeder bought 42,000 shares of the stock in a transaction dated Friday, March 25th. The shares were bought at an average cost of $24.79 per share, with a total value of $1,041,180.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) Director Thilo Schroeder bought 82,200 shares of the business’s stock in a transaction dated Friday, March 18th. The shares were bought at an average price of $20.30 per share, with a total value of $1,668,660.00. The transaction was disclosed in a filing with the SEC, which is available […]
Revolution Medicines (NASDAQ:RVMD – Get Rating) announced its earnings results on Monday. The company reported ($0.71) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.65) by ($0.06), MarketWatch Earnings reports. Revolution Medicines had a negative net margin of 587.91% and a negative return on equity of 26.76%. During the same […]